| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-63 |
Sentence |
denotes |
Identification of a novel glycosaminoglycan core-like molecule. |
| T1 |
0-63 |
Sentence |
denotes |
Identification of a novel glycosaminoglycan core-like molecule. |
| T2 |
64-67 |
Sentence |
denotes |
II. |
| T2 |
64-67 |
Sentence |
denotes |
II. |
| T3 |
68-129 |
Sentence |
denotes |
Alpha-GalNAc-capped xylosides can be made by many cell types. |
| T3 |
68-129 |
Sentence |
denotes |
Alpha-GalNAc-capped xylosides can be made by many cell types. |
| T4 |
130-179 |
Sentence |
denotes |
The accompanying article (Manzi, A., Salimath, P. |
| T4 |
130-179 |
Sentence |
denotes |
The accompanying article (Manzi, A., Salimath, P. |
| T5 |
180-193 |
Sentence |
denotes |
V., Spiro, R. |
| T5 |
180-193 |
Sentence |
denotes |
V., Spiro, R. |
| T6 |
194-208 |
Sentence |
denotes |
C., Keifer, P. |
| T6 |
194-208 |
Sentence |
denotes |
C., Keifer, P. |
| T7 |
209-227 |
Sentence |
denotes |
A., and Freeze, H. |
| T7 |
209-227 |
Sentence |
denotes |
A., and Freeze, H. |
| T8 |
228-240 |
Sentence |
denotes |
H. (1995) J. |
| T8 |
228-240 |
Sentence |
denotes |
H. (1995) J. |
| T9 |
241-246 |
Sentence |
denotes |
Biol. |
| T9 |
241-246 |
Sentence |
denotes |
Biol. |
| T10 |
247-252 |
Sentence |
denotes |
Chem. |
| T10 |
247-252 |
Sentence |
denotes |
Chem. |
| T11 |
253-414 |
Sentence |
denotes |
270, 9154-9163) reported the complete structure of a novel molecule made by human melanoma cells incubated with 1 mM 4-methylumbelliferyl-beta Xyl (Xyl beta MU). |
| T11 |
253-414 |
Sentence |
denotes |
270, 9154-9163) reported the complete structure of a novel molecule made by human melanoma cells incubated with 1 mM 4-methylumbelliferyl-beta Xyl (Xyl beta MU). |
| T12 |
415-691 |
Sentence |
denotes |
The product resembles a common pentasaccharide core region found in chondroitin/dermatan sulfate glycosaminoglycans, except that a terminal alpha-Gal-NAc residue is found in a location normally occupied by beta-GalNAc in these chains or alpha-GlcNAc in heparan sulfate chains. |
| T12 |
415-691 |
Sentence |
denotes |
The product resembles a common pentasaccharide core region found in chondroitin/dermatan sulfate glycosaminoglycans, except that a terminal alpha-Gal-NAc residue is found in a location normally occupied by beta-GalNAc in these chains or alpha-GlcNAc in heparan sulfate chains. |
| T13 |
692-829 |
Sentence |
denotes |
In this paper we show that several other human cancer cell lines and Chinese hamster ovary cells also make alpha-GalNAc-capped xylosides. |
| T13 |
692-829 |
Sentence |
denotes |
In this paper we show that several other human cancer cell lines and Chinese hamster ovary cells also make alpha-GalNAc-capped xylosides. |
| T14 |
830-1001 |
Sentence |
denotes |
The [6-3H]galactose-labeled Xyl beta MU product binds to immobilized alpha-GalNAc-specific lectin from Helix pomatia and the binding is competed by GalNAc, but not by Glc. |
| T14 |
830-1001 |
Sentence |
denotes |
The [6-3H]galactose-labeled Xyl beta MU product binds to immobilized alpha-GalNAc-specific lectin from Helix pomatia and the binding is competed by GalNAc, but not by Glc. |
| T15 |
1002-1116 |
Sentence |
denotes |
Binding to the lectin is destroyed by digestion with alpha-N-acetylgalactosaminidase, but not beta-hexosaminidase. |
| T15 |
1002-1116 |
Sentence |
denotes |
Binding to the lectin is destroyed by digestion with alpha-N-acetylgalactosaminidase, but not beta-hexosaminidase. |
| T16 |
1117-1322 |
Sentence |
denotes |
The nature of the aglycone influences the amount and relative proportion of this material made, with p-nitrophenyl-beta-xyloside being a better promoter of alpha-GalNAc-terminated product than Xyl beta MU. |
| T16 |
1117-1322 |
Sentence |
denotes |
The nature of the aglycone influences the amount and relative proportion of this material made, with p-nitrophenyl-beta-xyloside being a better promoter of alpha-GalNAc-terminated product than Xyl beta MU. |
| T17 |
1323-1586 |
Sentence |
denotes |
This novel oligosaccharide accounts for 45-65% of xyloside-based products made by both human melanoma and Chinese hamster ovary cells when they are incubated with 30 microM Xyl beta MU, but at 1 mM both the total amount and the proportion decreases to only 5-10%. |
| T17 |
1323-1586 |
Sentence |
denotes |
This novel oligosaccharide accounts for 45-65% of xyloside-based products made by both human melanoma and Chinese hamster ovary cells when they are incubated with 30 microM Xyl beta MU, but at 1 mM both the total amount and the proportion decreases to only 5-10%. |
| T18 |
1587-1695 |
Sentence |
denotes |
In both cell lines this product is replaced by a corresponding amount of Sia alpha 2,3Gal beta 4Xyl beta MU. |
| T18 |
1587-1695 |
Sentence |
denotes |
In both cell lines this product is replaced by a corresponding amount of Sia alpha 2,3Gal beta 4Xyl beta MU. |
| T19 |
1696-1871 |
Sentence |
denotes |
Preferential synthesis of the alpha-GalNAc-capped material at very low xyloside concentration argues that it is a normal biosynthetic product and not an experimental artifact. |
| T19 |
1696-1871 |
Sentence |
denotes |
Preferential synthesis of the alpha-GalNAc-capped material at very low xyloside concentration argues that it is a normal biosynthetic product and not an experimental artifact. |
| T20 |
1872-1979 |
Sentence |
denotes |
This pentasaccharide may be a previously unrecognized intermediate in glycosaminoglycan chain biosynthesis. |
| T20 |
1872-1979 |
Sentence |
denotes |
This pentasaccharide may be a previously unrecognized intermediate in glycosaminoglycan chain biosynthesis. |
| T21 |
1980-2188 |
Sentence |
denotes |
Since this alpha-GalNAc residue occurs at a position that determines whether chondroitin or heparan chains are added to the acceptor, it may influence the timing, type, and extent of further chain elongation. |
| T21 |
1980-2188 |
Sentence |
denotes |
Since this alpha-GalNAc residue occurs at a position that determines whether chondroitin or heparan chains are added to the acceptor, it may influence the timing, type, and extent of further chain elongation. |